Santen Pharmaceutical Co., Ltd. (TYO:4536)
Japan
· Delayed Price · Currency is JPY 1,618.50
-0.50 (-0.03%)
At close: Mar 9, 2026
Santen Pharmaceutical Revenue
Santen Pharmaceutical had revenue of 72.88B JPY in the quarter ending December 31, 2025, a decrease of -4.56%. This brings the company's revenue in the last twelve months to 287.99B, down -4.61% year-over-year. In the fiscal year ending March 31, 2025, Santen Pharmaceutical had annual revenue of 300.00B, down -0.65%.
Revenue (ttm)
287.99B
Revenue Growth
-4.61%
P/S Ratio
1.81
Revenue / Employee
74.82M
Employees
3,849
Market Cap
520.63B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 300.00B | -1.96B | -0.65% |
| Mar 31, 2024 | 301.97B | 22.93B | 8.22% |
| Mar 31, 2023 | 279.04B | 12.78B | 4.80% |
| Mar 31, 2022 | 266.26B | 16.65B | 6.67% |
| Mar 31, 2021 | 249.61B | 8.05B | 3.33% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Kyowa Kirin | 496.83B |
| Ono Pharmaceutical | 509.35B |
| JCR Pharmaceuticals | 37.55B |
| Astellas Pharma | 2,060.61B |
| Daiichi Sankyo Company | 2,052.15B |
| Otsuka Holdings | 2,468.89B |
| Chugai Pharmaceutical | 1,257.94B |
| Perseus Proteomics | 140.41M |